{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:17:56Z","timestamp":1771237076298,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,6,11]],"date-time":"2008-06-11T00:00:00Z","timestamp":1213142400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1471-2415-8-11","type":"journal-article","created":{"date-parts":[[2008,6,11]],"date-time":"2008-06-11T14:14:37Z","timestamp":1213193677000},"source":"Crossref","is-referenced-by-count":15,"title":["Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: A patient-use study"],"prefix":"10.1186","volume":"8","author":[{"given":"Mauricio D","family":"Paolera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niro","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano C","family":"Umbelino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G","family":"Walt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,11]]},"reference":[{"key":"131_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/BF02853166","volume":"18","author":"R Noecker","year":"2001","unstructured":"Noecker R: Effects of common ophthalmic preservatives on ocular health. Adv Ther. 2001, 18: 205-215. 10.1007\/BF02853166.","journal-title":"Adv Ther"},{"key":"131_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/BF02850299","volume":"18","author":"S Gandolfi","year":"2001","unstructured":"Gandolfi S, Simmons ST, Sturm R, Chen K, VanDenburgh AM, the Bimatoprost Study Group 3: Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv Ther. 2001, 18: 110-121. 10.1007\/BF02850299.","journal-title":"Adv Ther"},{"key":"131_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0002-9394(02)01827-5","volume":"135","author":"RJ Noecker","year":"2003","unstructured":"Noecker RJ, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM, the Bimatoprost\/Latanoprost Study Group: A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol. 2003, 135: 55-63. 10.1016\/S0002-9394(02)01827-5.","journal-title":"Am J Ophthalmol"},{"issue":"Suppl 4","key":"131_CR4","doi-asserted-by":"publisher","first-page":"S361","DOI":"10.1016\/S0039-6257(01)00219-3","volume":"145","author":"M Sherwood","year":"2001","unstructured":"Sherwood M, Brandt J, the Bimatoprost Study Groups 1 and 2: Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Surv Ophthalmol. 2001, 145 (Suppl 4): S361-S368. 10.1016\/S0039-6257(01)00219-3.","journal-title":"Surv Ophthalmol"},{"key":"131_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/bjo.79.1.12","volume":"79","author":"A Alm","year":"1995","unstructured":"Alm A, Wideng\u00e5rd I, Kjellgren D, S\u00f6derstr\u00f6m M, Fristr\u00f6m B, Heijl A, Stjerschantz J: Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol. Br J Ophthalmol. 1995, 79: 12-21. 10.1136\/bjo.79.1.12.","journal-title":"Br J Ophthalmol"},{"issue":"Suppl 2","key":"131_CR6","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1016\/S0039-6257(97)80016-1","volume":"41","author":"A Alm","year":"1997","unstructured":"Alm A, Camras CB, Watson PG: Phase III latanoprost studies in Scandinavia, the United Kingdom, and the United States. Surv Ophthalmol. 1997, 41 (Suppl 2): S105-S110.","journal-title":"Surv Ophthalmol"},{"key":"131_CR7","unstructured":"Xalatan\u00ae (latanoprost ophthalmic solution) 0.005%. Package insert. 2006"},{"key":"131_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/00061198-200110000-00007","volume":"10","author":"PV Morgan","year":"2001","unstructured":"Morgan PV, Proniuk S, Blanchard J, Noecker RJ: Effect of temperature and light on the stability of latanoprost and its clinical relevance. J Glaucoma. 2001, 10: 401-405. 10.1097\/00061198-200110000-00007.","journal-title":"J Glaucoma"},{"key":"131_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1127\/0941-2948\/2006\/0130","volume":"15","author":"M Kottek","year":"2006","unstructured":"Kottek M, Grieser J, Beck C, Rudolf B, Rubel F: World Map of K\u00f6ppen-Geiger Climate Classification updated. Meteorol Z. 2006, 15: 259-263. 10.1127\/0941-2948\/2006\/0130. Accessed May 30, 2007, [\n                    http:\/\/koeppen-geiger.vu-wien.ac.at\n                    \n                  ]","journal-title":"Meteorol Z"},{"key":"131_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1167\/iovs.04-1367","volume":"47","author":"R Varma","year":"2006","unstructured":"Varma R, Winarko J, Kiat-Winarko T, Winarko B: Concentration of latanoprost ophthalmic solution after 4 to 6 weeks' use in an eye clinic setting. Invest Ophthalmol Vis Sci. 2006, 47: 222-225. 10.1167\/iovs.04-1367.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"131_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijpharm.2005.08.017","volume":"305","author":"Y Sakai","year":"2005","unstructured":"Sakai Y, Yasueda S-I, Ohtori A: Stability of latanoprost in an ophthalmic lipid emulsion using polyvinyl alcohol. Int J Pharmaceutics. 2005, 305: 176-179. 10.1016\/j.ijpharm.2005.08.017.","journal-title":"Int J Pharmaceutics"},{"key":"131_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/00061198-200112000-00008","volume":"10","author":"GD Novack","year":"2001","unstructured":"Novack GD, Evans R: Commercially available ocular hypotensive products: preservative concentration, stability, storage, and in-life utilization. J Glaucoma. 2001, 10: 483-486. 10.1097\/00061198-200112000-00008.","journal-title":"J Glaucoma"},{"issue":"Suppl 4","key":"131_CR13","doi-asserted-by":"publisher","first-page":"S353","DOI":"10.1016\/S0039-6257(01)00212-0","volume":"45","author":"H DuBiner","year":"2001","unstructured":"DuBiner H, Cooke D, Dirks M, Stewart WC, VanDenburgh AM, Felix C: Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost. Surv Ophthalmol. 2001, 45 (Suppl 4): S353-60. 10.1016\/S0039-6257(01)00212-0.","journal-title":"Surv Ophthalmol"},{"key":"131_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/BF02850299","volume":"18","author":"S Gandolfi","year":"2001","unstructured":"Gandolfi S, Simmons ST, Sturm R, Chen K, VanDenburgh AM, Bimatoprost Study Group 3: Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv Ther. 2001, 18: 110-21. 10.1007\/BF02850299.","journal-title":"Adv Ther"},{"issue":"Suppl 1","key":"131_CR15","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.survophthal.2003.12.017","volume":"49","author":"TR Walters","year":"2004","unstructured":"Walters TR, DuBiner HB, Carpenter SP, Khan B, VanDenburgh AM, Bimatoprost Circadian IOP Study Group: 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial. Surv Ophthalmol. 2004, 49 (Suppl 1): S26-35. 10.1016\/j.survophthal.2003.12.017.","journal-title":"Surv Ophthalmol"},{"key":"131_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/BF02850159","volume":"23","author":"MS Dirks","year":"2006","unstructured":"Dirks MS, Noecker RJ, Earl M, Roh S, Silverstein SM, Williams RD: A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma. Adv Ther. 2006, 23: 385-94. 10.1007\/BF02850159.","journal-title":"Adv Ther"},{"key":"131_CR17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0002-9394(03)00098-9","volume":"135","author":"RK Parrish","year":"2003","unstructured":"Parrish RK, Palmberg P, Sheu WP, XLT Study Group: A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol. 2003, 135: 688-703. 10.1016\/S0002-9394(03)00098-9.","journal-title":"Am J Ophthalmol"},{"key":"131_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF02850157","volume":"21","author":"ST Simmons","year":"2004","unstructured":"Simmons ST, Dirks MS, Noecker RJ: Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: results from parallel-group comparison trials. Adv Ther. 2004, 21: 247-62. 10.1007\/BF02850157.","journal-title":"Adv Ther"},{"key":"131_CR19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1185\/030079907X178720","volume":"23","author":"P Denis","year":"2007","unstructured":"Denis P, Lafuma A, Khoshnood B, Mimaud V, Berdeaux G: A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy. Curr Med Res Opin. 2007, 23: 601-8. 10.1185\/030079907X178720.","journal-title":"Curr Med Res Opin"},{"key":"131_CR20","volume-title":"Presented at the Annual Meeting of the American Academy of Ophthalmology","author":"K Nouri-Mahdavi","year":"2003","unstructured":"Nouri-Mahdavi K, Hoffman D, Gaasterland DE, Capriolo J: Intraocular pressure fluctuation is a risk factor for glaucomatous visual field progression in AGIS. Presented at the Annual Meeting of the American Academy of Ophthalmology. 2003"},{"key":"131_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/00061198-200004000-00002","volume":"9","author":"S Asrani","year":"2000","unstructured":"Asrani S, Zeimer R, Wilensky J, Gieser D, Vitale S, Lindenmuth K: Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000, 9: 134-142.","journal-title":"J Glaucoma"},{"key":"131_CR22","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1136\/bjo.81.10.867","volume":"81","author":"B Fristr\u00f6m","year":"1997","unstructured":"Fristr\u00f6m B, Nilsson SEG: A double masked comparison of the intraocular pressure reducing effect of latanoprost 0.005% and 0.001% administered once daily in open angle glaucoma and ocular hypertension. Br J Ophthalmol. 1997, 81: 867-870.","journal-title":"Br J Ophthalmol"},{"key":"131_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/BF01007833","volume":"235","author":"M Diestelhorst","year":"1997","unstructured":"Diestelhorst M, Roters S, Krieglstein GK: The effect of latanoprost 0.005% once daily versus 0.0015% twice daily on intraocular pressure and aqueous humour protein concentration in glaucoma patients: a randomized, double masked comparison with timolol 0.5%. Graefes Arch Clin Exp Ophthalmol. 1997, 235: 20-6. 10.1007\/BF01007833.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"131_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1124\/jpet.102.047837","volume":"305","author":"DF Woodward","year":"2003","unstructured":"Woodward DF, Krauss AH, Chen J, Liang Y, Li C, Protzman CE, Bogardus A, Chen R, Kedzie KM, Krauss HA, Gil DW, Kharlamb A, Wheeler LA, Babusis D, Welty D, Tang-Liu DD, Cherukury M, Andrews SW, Burk RM, Garst ME: Pharmacological characterization of a novel antiglaucoma agent, bimatoprost (AGN 192024). J Pharmacol Exp Ther. 2003, 305: 772-785. 10.1124\/jpet.102.047837.","journal-title":"J Pharmacol Exp Ther"},{"key":"131_CR25","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/archopht.119.7.994","volume":"119","author":"RA Laibovitz","year":"2001","unstructured":"Laibovitz RA, VanDenburgh AM, Felix C, David R, Batoosingh A, Rosenthal A, Cheetham J: Comparison of the ocular hypotensive lipid AGN 192024 with timolol. Arch Ophthalmol. 2001, 119: 994-1000.","journal-title":"Arch Ophthalmol"},{"key":"131_CR26","unstructured":"Lumigan\u00ae (bimatoprost ophthalmic solution) 0.03%. Package insert. 2006"},{"key":"131_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1089\/jop.2006.22.477","volume":"22","author":"R Fiscella","year":"2006","unstructured":"Fiscella R, Wilensky JT, Chiang TH, Walt JG: Efficiency of instillation methods for prostaglandin medications. J Ocul Pharmacol Ther. 2006, 22: 477-482. 10.1089\/jop.2006.22.477.","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2415-8-11\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-8-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-8-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-8-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T21:53:12Z","timestamp":1548193992000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/1471-2415-8-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,11]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["131"],"URL":"https:\/\/doi.org\/10.1186\/1471-2415-8-11","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,11]]},"article-number":"11"}}